Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04633954Completed
Randomised, open-label trial of brimonidine in subconjunctival hemorrhage (SCH) (2 arms), sponsored by Uptown Eye Specialists. Primary endpoint: Bulbar Redness. Started Jun 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04633954.